Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126309181 | 12630918 | 1 | I | 20150925 | 20160808 | 20160808 | PER | US-PFIZER INC-3027380 | PFIZER | 56.00 | YR | M | Y | 0.00000 | 20160808 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126309181 | 12630918 | 1 | PS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 750 MG, TOTAL DOSE: 1500 MG, FREQ: 2 DAY; INTERVAL: 1 | U | UNK | 62911 | 750 | MG | ||||||
| 126309181 | 12630918 | 2 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 500 MG, TOTAL DOSE: 1000 MG, EVERY 12 HOURS, FREQ: 2 DAY; INTERVAL: 1 | U | UNK | 62911 | 500 | MG | ||||||
| 126309181 | 12630918 | 3 | SS | BUMEX | BUMETANIDE | 1 | Oral | 1 MG, 2 MG, FREQ: 2 DAY; INTERVAL: 1 | 0 | 1 | MG | ||||||||
| 126309181 | 12630918 | 4 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | Unknown | 0 | |||||||||||
| 126309181 | 12630918 | 5 | C | HUMULIN NOS | INSULIN HUMAN | 1 | Subcutaneous | 25 UNITS, FREQ: 2 DAY; INTERVAL:1 | 0 | ||||||||||
| 126309181 | 12630918 | 6 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Oral | 1 PACKET MIXED WITH 8 OZ OF FLUID, FREQ: 1 DAY; INTERVAL: 1 | 0 | ||||||||||
| 126309181 | 12630918 | 7 | C | VFEND | VORICONAZOLE | 1 | Oral | 1 DF, STRENGTH: 200MG, TOTAL DOSE: 400MG, FREQ: 1 HOUR; INTERVAL: 12 | 0 | 1 | DF | ||||||||
| 126309181 | 12630918 | 8 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 1 DF, STRENGTH: 1 MG, FREQ: 2 DAY; INTERVAL: 1 | 0 | 1 | DF | ||||||||
| 126309181 | 12630918 | 9 | C | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Oral | 1 DF, STRENGTH: 5 MG, FREQ: 1 DAY; INTERVAL: 1 | 0 | 1 | DF | ||||||||
| 126309181 | 12630918 | 10 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | 1 DF, STRENGTH: 81 MG, FREQ: 1 DAY; INTERVAL: 1 | 0 | 1 | DF | TABLET | |||||||
| 126309181 | 12630918 | 11 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 1 DF, STRENGTH: 12.5 MG, WITH FOOD, FREQ: 2 DAY; INTERVAL: 1 | 0 | 1 | DF | ||||||||
| 126309181 | 12630918 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 1 DF, STRENGTH: 40 MG, TOTAL DOSE: 80 MG, FREQ: 2 DAY; INTERVAL: 1 | 0 | 1 | DF | TABLET | |||||||
| 126309181 | 12630918 | 13 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 1 DF, STRENGTH: 25 MG, TOTAL DOSE: 75 MG, FREQ: 1 HOUR; INTERVAL: 8 | 0 | 1 | DF | TABLET | |||||||
| 126309181 | 12630918 | 14 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 1 DF, STRENGTH: 600 MG, TOTAL DOSE: 1800, FREQ: 3 DAY; INTERVAL: 1 | 0 | 1 | DF | ||||||||
| 126309181 | 12630918 | 15 | C | LINAGLIPTIN | LINAGLIPTIN | 1 | Oral | 1 DF, STRENGTH: 5 MG, FREQ: 1 DAY; INTERVAL: 1 | 0 | 1 | DF | TABLET | |||||||
| 126309181 | 12630918 | 16 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 1 DF, STRENGTH: 25 MG | 0 | 1 | DF | TABLET | |||||||
| 126309181 | 12630918 | 17 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 1 DF, STRENGTH: 45 MG, BEFORE BEDTIME IN THE EVENING, FREQ: 1 DAY; INTERVAL: 1 | 0 | 1 | DF | TABLET | |||||||
| 126309181 | 12630918 | 18 | C | MULTIVITAMINS | VITAMINS | 1 | Oral | 0 | |||||||||||
| 126309181 | 12630918 | 19 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | Oral | 30 MG, TOTAL DOSE: 60 MG, AS REQUIRED, FREQ: 2 DAY; INTERVAL: 1 | 0 | 30 | MG | ||||||||
| 126309181 | 12630918 | 20 | C | PANTOPRAZOLE SODIUM SESQUIHYDRATE | PANTOPRAZOLE SODIUM | 1 | Oral | 1 DF, STRENGTH: 40 MG, FREQ: 1 DAY; INTERVAL: 1 | 0 | 1 | DF | TABLET | |||||||
| 126309181 | 12630918 | 21 | C | POTASSIUM | POTASSIUM | 1 | Oral | 20 MG, FREQ: 1 DAY; INTERVAL: 1 | 0 | 20 | MG | ||||||||
| 126309181 | 12630918 | 22 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 1 DF, STRENGTH: 40 MG, FREQ: 1 DAY; INTERVAL: 1 | 0 | 1 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126309181 | 12630918 | 1 | Product used for unknown indication |
| 126309181 | 12630918 | 3 | Product used for unknown indication |
| 126309181 | 12630918 | 4 | Product used for unknown indication |
| 126309181 | 12630918 | 5 | Product used for unknown indication |
| 126309181 | 12630918 | 6 | Product used for unknown indication |
| 126309181 | 12630918 | 7 | Aspergillus test positive |
| 126309181 | 12630918 | 8 | Product used for unknown indication |
| 126309181 | 12630918 | 9 | Product used for unknown indication |
| 126309181 | 12630918 | 10 | Product used for unknown indication |
| 126309181 | 12630918 | 11 | Product used for unknown indication |
| 126309181 | 12630918 | 12 | Product used for unknown indication |
| 126309181 | 12630918 | 13 | Product used for unknown indication |
| 126309181 | 12630918 | 14 | Product used for unknown indication |
| 126309181 | 12630918 | 15 | Product used for unknown indication |
| 126309181 | 12630918 | 16 | Product used for unknown indication |
| 126309181 | 12630918 | 17 | Product used for unknown indication |
| 126309181 | 12630918 | 18 | Product used for unknown indication |
| 126309181 | 12630918 | 19 | Product used for unknown indication |
| 126309181 | 12630918 | 20 | Product used for unknown indication |
| 126309181 | 12630918 | 21 | Product used for unknown indication |
| 126309181 | 12630918 | 22 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126309181 | 12630918 | Blood creatinine increased | |
| 126309181 | 12630918 | Drug level increased | |
| 126309181 | 12630918 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |